Dr. Parker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
Mail Code 0987
La Jolla, CA 92093Phone+1 858-249-3248Fax+1 858-249-3250
Summary
- I am a breast medical oncologist and former senior cancer center administrator with over 30 years of experience in clinical care, clinical and translational research, cancer strategic planning and cancer clinical operations.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1987- University of California (San Diego) Medical CenterChief Residency, Internal Medicine, 1984 - 1985
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1981 - 1984
Stanford University School of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1982 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Docs San Diego 2006-2020
- Lifetime Achievement Award American Cancer Society San Diego, 2019
- Lifetime Achievement Award UCSD Moores Cancer Center, 2018
- Join now to see all
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Publications & Presentations
PubMed
- 30 citationsThe Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care.Sarah L. Elson, Robert A. Hiatt, Hoda Anton-Culver, Lydia P. Howell, Arash Naeim
Breast Cancer Research and Treatment. 2013-07-26 - 75 citationsThe neoadjuvant model is still the future for drug development in breast cancerAngela De Michele, Douglas Yee, Donald A. Berry, Kathy S. Albain, Christopher C. Benz
Clinical Cancer Research. 2015-02-24 - 9 citationsThe oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 -) advanced/metastati...Aditya Bardia, Ingrid Mayer, Eric Winer, Hannah M Linden, Cynthia X Ma
Breast Cancer Research and Treatment. 2023-01-01
Press Mentions
Researchers to Test Novel Drug Combination Against Toughest Breast CancersAugust 27th, 2018
UCSD Launches New Clinical Trial for Breast Cancer DrugAugust 27th, 2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
